Cerevel Therapeutics Holdings Inc (DELISTED) (CERE:DL)
44.96
0.00 (0.00%)
USD |
NASDAQ |
Aug 01, 16:00
Cerevel Therapeutics Holdings Price to Book Value: 14.51 for Aug. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 01, 2024 | 14.51 |
| July 31, 2024 | 14.51 |
| July 30, 2024 | 14.41 |
| July 29, 2024 | 14.33 |
| July 26, 2024 | 14.40 |
| July 25, 2024 | 14.33 |
| July 24, 2024 | 14.00 |
| July 23, 2024 | 14.01 |
| July 22, 2024 | 14.02 |
| July 19, 2024 | 13.85 |
| July 18, 2024 | 13.78 |
| July 17, 2024 | 13.79 |
| July 16, 2024 | 13.70 |
| July 15, 2024 | 13.52 |
| July 12, 2024 | 13.01 |
| July 11, 2024 | 13.25 |
| July 10, 2024 | 13.21 |
| July 09, 2024 | 13.08 |
| July 08, 2024 | 13.10 |
| July 05, 2024 | 13.22 |
| July 03, 2024 | 13.01 |
| July 02, 2024 | 13.31 |
| July 01, 2024 | 13.35 |
| June 28, 2024 | 13.20 |
| June 27, 2024 | 13.07 |
| Date | Value |
|---|---|
| June 26, 2024 | 12.58 |
| June 25, 2024 | 12.77 |
| June 24, 2024 | 13.37 |
| June 21, 2024 | 13.44 |
| June 20, 2024 | 13.45 |
| June 18, 2024 | 13.51 |
| June 17, 2024 | 13.39 |
| June 14, 2024 | 13.41 |
| June 13, 2024 | 13.42 |
| June 12, 2024 | 13.25 |
| June 11, 2024 | 13.00 |
| June 10, 2024 | 13.00 |
| June 07, 2024 | 12.92 |
| June 06, 2024 | 13.00 |
| June 05, 2024 | 13.20 |
| June 04, 2024 | 13.12 |
| June 03, 2024 | 13.11 |
| May 31, 2024 | 13.15 |
| May 30, 2024 | 13.12 |
| May 29, 2024 | 13.18 |
| May 28, 2024 | 13.23 |
| May 24, 2024 | 13.34 |
| May 23, 2024 | 13.44 |
| May 22, 2024 | 13.44 |
| May 21, 2024 | 13.48 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
4.094
Minimum
Mar 30 2021
28.08
Maximum
Dec 28 2023
10.20
Average
9.809
Median
Sep 29 2023
Price to Book Value Benchmarks
| AbbVie Inc | 50.42 |
| Amgen Inc | 30.59 |
| Biogen Inc | 1.828 |
| Gilead Sciences Inc | 5.717 |
| Eli Lilly and Co | 61.18 |
Price to Book Value Related Metrics
| Price | 44.96 |
| Earnings Yield | -6.07% |
| Market Cap | 8.191B |